Where can Singapore take the lead in alternative proteins?
Tessa Oh
SINGAPORE is investing heavily in alternative proteins in a bid to become a world leader – but its status as a global hub, especially for manufacturing, may be threatened as other countries catch up.
Alternative proteins do not involve the slaughter of animals; they may be plant-based, fermented using microbes, or cultivated from animal cells.
In Singapore, investments in such proteins multiplied to US$169.8 million by 2022, from just US$5.9 million in 2019, according to think tank Good Food Institute (GFI). This was part of the US$562 million Asia-Pacific total in 2022, up from US$42 million in 2019.
TRENDING NOW
When every phone becomes a satellite phone, what happens to Asia’s telcos?
Koh Brothers Eco Engineering faces up to S$57.6 million in potential liabilities from legal disputes
Too little, too late? Manila’s billion-dollar bid to ignite its sputtering EV industry
DayOne secures S$530 million green loan from DBS, OCBC and UOB for Singapore data centre